1OA Stock Overview
Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Blueberries Medical Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.01 |
| 52 Week High | CA$0.03 |
| 52 Week Low | CA$0.001 |
| Beta | 1.51 |
| 1 Month Change | 0% |
| 3 Month Change | -50.00% |
| 1 Year Change | -31.03% |
| 3 Year Change | -88.51% |
| 5 Year Change | -98.17% |
| Change since IPO | -95.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1OA | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.1% | -2.0% |
| 1Y | -31.0% | -31.9% | -0.3% |
Return vs Industry: 1OA exceeded the German Pharmaceuticals industry which returned -32.1% over the past year.
Return vs Market: 1OA underperformed the German Market which returned -0.2% over the past year.
Price Volatility
| 1OA volatility | |
|---|---|
| 1OA Average Weekly Movement | 32.2% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 1OA's share price has been volatile over the past 3 months.
Volatility Over Time: 1OA's weekly volatility has decreased from 68% to 32% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Facundo Garreton | blueberriesmed.com |
Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. It produces psychoactive and non-psychoactive cannabis by-products. Blueberries Medical Corp. is based in Vancouver, Canada.
Blueberries Medical Corp. Fundamentals Summary
| 1OA fundamental statistics | |
|---|---|
| Market cap | €6.81m |
| Earnings (TTM) | -€853.72k |
| Revenue (TTM) | €195.02k |
34.9x
P/S Ratio-8.0x
P/E RatioIs 1OA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1OA income statement (TTM) | |
|---|---|
| Revenue | CA$285.66k |
| Cost of Revenue | CA$175.90k |
| Gross Profit | CA$109.77k |
| Other Expenses | CA$1.36m |
| Earnings | -CA$1.25m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0031 |
| Gross Margin | 38.43% |
| Net Profit Margin | -437.76% |
| Debt/Equity Ratio | 284.4% |
How did 1OA perform over the long term?
See historical performance and comparison